GPC1 and metastatic neoplasm: Levels of GPC1+ exosomes also correlated with tumor burden in patients with PDAC: patients with distant metastatic disease had significantly higher levels (average of 58.5%) when compared to patients with metastatic disease restricted to lymph nodes (average of 50.5%) or no metastases (average of 39.9%).